In the latest issue of International Clinical Trials magazine published by Samedan Ltd, Derek Ansel, our Executive Director and Therapeutic Strategy Lead for Rare Disease, dives into the complex world of rare disease research. In this article, Derek shares how genetic counselors bridge the divide between patients and groundbreaking clinical trials. Flip to pages 34-37 to uncover their indispensable role in patient recruitment and retention and what we can do to bolster resources in rare disease studies.
Read Derek’s article here.
